Osteosarcoma, advanced

Clinical trials for Osteosarcoma, advanced explained in plain language.

Never miss a new study

Get alerted when new Osteosarcoma, advanced trials appear

Sign up with your email to follow new studies for Osteosarcoma, advanced, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a smart drug hunt down sarcoma cells without harming healthy ones?

Disease control Not yet recruiting

This trial tests SOT106, a cancer medicine designed to find and kill cells that carry a marker called LRRC15, which appears on some osteosarcoma and soft tissue sarcoma tumors. The study has two parts: the first finds safe dose levels, and the second compares two doses to see whi…

Matched conditions: OSTEOSARCOMA, ADVANCED

Phase 1/2 • Sponsor: SOTIO Biotech a.s. • Aim: Disease control

Last updated Sep 05, 2026 00:00 UTC

Osteosarcoma, advanced

Get alerted when new Osteosarcoma, advanced trials appear

Can a smart drug hunt down sarcoma cells without harming healthy ones?